Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale Director sold 5,000 shares at $40.00 ($200,000)
  2. 4 Open-market sale Director sold 2,000 shares at an average $34.75 ($69,496)
  3. 4 Open-market sale Chief Scientific Officer sold 77,700 shares at an average $36.85 ($2,863,365)
  4. 4 Open-market sale SVP, Clinical Diagnostics sold 40,000 shares at $38.01 ($1,520,400)
  5. 4/A Open-market sale Chief Financial Officer sold 15,000 shares at an average $24.47 ($367,029)
  6. 4 Open-market sale President sold 110,000 shares at an average $38.10 ($4,190,780)
  7. 4 Open-market sale Chief Financial Officer sold 20,000 shares at $35.92 ($718,400)
  8. 4/A Open-market sale Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale CEO and Chairman sold 45,000 shares at an average $35.60 ($1,601,967)
  13. 4 Open-market sale Chief Medical Officer sold 50,000 shares at an average $33.86 ($1,692,885)
  14. 4 Open-market sale Director sold 5,000 shares at $35.00 ($175,000)
  15. 8-K Event Regulation FD disclosure
  16. 4 Open-market sale SVP and General Counsel sold 19,580 shares at $30.22 ($591,708)
  17. 4 Open-market sale Director sold 25,000 shares at $29.77 ($744,250)
  18. DEFA14A Proxy Proxy Materials
  19. DEF 14A Proxy Proxy Statement
  20. 4 Open-market sale Chief Scientific Officer sold 44,400 shares at an average $29.70 ($1,318,516)

Page 35 of 42 · 837 filings